Body composition and prevalence of left ventricular hypertrophy

被引:0
|
作者
Kuch, B
Hense, HW
Gneiting, B
Döring, A
Muscholl, M
Bröckel, U
Schunkert, H
机构
[1] Univ Munster, Bereich Klin Epidemiol, Inst Epidemiol & Sozialmed, Clin Epidemiol Unit, D-48129 Munster, Germany
[2] GSF Forschungszentrum Umwelt & Gesundheit, Inst Epidemiol, Munich, Germany
[3] Univ Regensburg, Dept Internal Med 2, D-8400 Regensburg, Germany
[4] Cent Hosp, Dept Internal Med 1, Augsburg, Germany
关键词
hypertrophy; fat-free mass; obesity; epidemiology;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Fat-free mass (FFM) has been proposed as an optimal normalization of left ventricular (LV) mass to body size. We sought to evaluate the novel FFM-based criteria of LV hypertrophy (LVH). Methods and Results-A population sample of 1371 men and women aged 25 to 74 years was examined by echocardiography and bioelectrical impedance analysis. Internal partition values for LVH were generated in a healthy population subgroup on the basis of LV mass divided by FFM and by the traditional indexations to body height, height(2 7), and body surface area. In contrast to the sex-specific criteria required by traditional indexations, the value of LV mass/FFM that divided individuals with and without LVH was identical for men and women (4.1 g/kg). Estimates of LVH prevalence varied significantly by type of indexation used, internally or externally derived cut points, and by population subgroups. Differences were pronounced among hypertensives and the obese. Thus, the application of LV mass/FFM more than halved the risk of LVH in obese versus nonobese women (odds ratio, 2.5; 95% confidence interval, 1.6 to 4.0) compared with criteria based on LV masskeight(2.7) (odds ratio, 5.5; 95% confidence interval, 3.6 to 8.3). Implications among hypertensives were less marked. Conclusions-Indexation of LV mass to FFM eliminates sex-specific LVH criteria. The proportion of individuals defined as having LVH using the new criteria deviate markedly from traditional indexations. Prospective investigations will be needed to identify the prognostic implications of different indexations, especially in subgroups such as the obese.
引用
收藏
页码:405 / 410
页数:6
相关论文
共 50 条
  • [21] Prevalence of abnormal left ventricular geometry and predictors of left ventricular hypertrophy in patients with rheumatoid arthritis
    Ruangpan, K.
    Nilmoje, T.
    Aiewruengsurat, D.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2646 - 2646
  • [22] Indexation of left ventricular mass, prevalence of left ventricular hypertrophy and predictive role of blood pressure
    Ferrara, LA
    Vaccaro, O
    Cardoni, O
    Mancini, M
    Zanchetti, A
    JOURNAL OF HYPERTENSION, 2004, 22 : S93 - S93
  • [23] Sex Difference in the Prevalence of Left Ventricular Hypertrophy in Dialysis Patients
    Cheng, Li-Tao
    Gao, Yan-Li
    Tian, Jun-Ping
    Gu, Yue
    Zhang, Li
    Bi, Shu-Hong
    Tang, Wen
    Lindholm, Bengt
    Wang, Tao
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (05) : 398 - 405
  • [24] Left Ventricular Hypertrophy in Hypertensive Children and Adolescents: Predictors and Prevalence
    Rae-Ellen W. Kavey
    Current Hypertension Reports, 2013, 15 : 453 - 457
  • [25] LEFT-VENTRICULAR HYPERTROPHY - PREVALENCE IN OLDER PATIENTS AND MANAGEMENT
    PACIARONI, E
    FRATICELLI, A
    DRUGS & AGING, 1995, 6 (04) : 301 - 311
  • [26] Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy
    Kim, Woo-Shik
    Kim, Hyun Soo
    Shin, Jinho
    Park, Ijong Chun
    Yoo, Han-Wook
    Takenaka, Toshihiro
    Tei, Chuwa
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (07)
  • [27] Prevalence and Clinical Correlates of Left Ventricular Hypertrophy in Black Africans
    Baldo M.P.
    Gonçalves M.A.
    Capingana D.P.
    Magalhães P.
    da Silva A.B.T.
    Mill J.G.
    High Blood Pressure & Cardiovascular Prevention, 2018, 25 (3) : 283 - 289
  • [28] Regional differences in the prevalence of left ventricular hypertrophy within Germany
    Voelzke, Henry
    Stritzke, Jan
    Kuch, Bernhard
    Schmidt, Carsten O.
    Luedemann, Jan
    Doering, Angela
    Schunkert, Heribert
    Hense, Hans-Werner
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2009, 16 (03): : 392 - 400
  • [29] LEFT-VENTRICULAR HYPERTROPHY - ITS PREVALENCE, ETIOLOGY, AND SIGNIFICANCE
    WEBER, JR
    CLINICAL CARDIOLOGY, 1991, 14 (07) : 13 - 17
  • [30] Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors
    Mark M. Mitsnefes
    Stephen R. Daniels
    Steven M. Schwartz
    Richard A. Meyer
    Philip Khoury
    C. Frederic Strife
    Pediatric Nephrology, 2000, 14 : 898 - 902